| Literature DB >> 34689755 |
Junfang Sun1, Bowen Weng2, Xiaoyue Zhang2, Xiaoyun Chu2, Cheng Cai3.
Abstract
BACKGROUND: Pulmonary hypertension (PH) is a common complication of bronchopulmonary dysplasia (BPD) in very-low-birth-weight infants (VLBWIs). Although recent studies have increased awareness that PH contributes significantly to the high morbidity and mortality of BPD, the risk factors and clinical characteristics for PH in VLBWIs are little known.Entities:
Keywords: Bronchopulmonary dysplasia; Pulmonary hypertension; Risk factor; Very-low-birth-weight infants
Mesh:
Year: 2021 PMID: 34689755 PMCID: PMC8542187 DOI: 10.1186/s12872-021-02330-w
Source DB: PubMed Journal: BMC Cardiovasc Disord ISSN: 1471-2261 Impact factor: 2.298
Fig. 1Flow diagram showing the study design of BPD-PH infants enrolled in this study
NICHD diagnostic criteria for severity of BPD
| BPD severity | Criteria |
|---|---|
| Mild | Supplemental oxygen required ≥ 28 days, termination of supplemental oxygen by 36 weeks cGA or discharge |
| Moderate | Supplemental oxygen required ≥ 28 days, requirement of < 30% O2 at 36 weeks cGA or discharge |
| Severe | Supplemental oxygen required ≥ 28 days, requirement of ≥ 30% O2 and/or continuous positive airway pressure or mechanical ventilation at 36 weeks cGA or discharge |
Baseline clinical characteristics of the study population
| Clinical characteristics | All study patients (n = 83) | Non-PH (n = 65) | PH (n = 18) | |
|---|---|---|---|---|
| Male | 46(55%) | 35(54%) | 11(61%) | 0.583 |
| Birth weight, g | 1078.1 ± 194.0 | 1108.5 ± 185.8 | 968.1 ± 187.7 | 0.006 |
| Gestational age, weeks | 28.3 ± 1.3 | 28.4 ± 1.2 | 27.9 ± 1.3 | 0.132 |
| 0–3 | 1(1%) | 0(0) | 1(6%) | |
| 4–7 | 15(18%) | 13(20%) | 2(11%) | 0.120 |
| 8–10 | 67(81%) | 52(80%) | 15(83%) | |
| Small for gestational age | 5(6%) | 2(3%) | 3(17%) | 0.066 |
| Cesarean section | 41(49%) | 32(49%) | 9(50%) | 0.954 |
| Maternal age, ≥ 35 | 14(17%) | 9(14%) | 5(28%) | 0.162 |
| Gestational diabetes | 7(8%) | 5(8%) | 2(11%) | 0.644 |
| Gestational hypertension | 14(17%) | 11(17%) | 3(17%) | 0.979 |
| PPROM | 18(22%) | 14(22%) | 4(22%) | 0.950 |
| Placental abruption | 11(13%) | 9(14%) | 2(11%) | 0.762 |
| BPD severity | ||||
| mild | 38(46%) | 32(49%) | 6(33%) | |
| moderate | 27(32%) | 22(34%) | 5(28%) | 0.130 |
| severe | 18(22%) | 11(17%) | 7(39%) | |
| Pulmonary surfactant | 73(88%) | 56(86%) | 17(94%) | 0.339 |
| Respiratory distress syndrome | 82(99%) | 64(98%) | 18(100%) | 0.597 |
| Duration of O2 therapy, days | 58.9 ± 28.0 | 55.5 ± 27.8 | 70.9 ± 26.1 | 0.038 |
| Duration of mechanical ventilation, days | 51.4 ± 27.5 | 48.0 ± 27.2 | 63.9 ± 25.4 | 0.028 |
| Duration of hospitalization, days | 75.0 ± 24.5 | 73.1 ± 25.2 | 81.9 ± 20.8 | 0.178 |
| Hypoxemia | 81(98%) | 63(97%) | 18(100%) | 0.451 |
| NEC, stage ≥ 2 | 6(7%) | 5(8%) | 1(6%) | 1.000 |
| Home oxygen | 3(4%) | 2(3%) | 1(6%) | 0.525 |
| Death | 3(4%) | 1(2%) | 2(11%) | 0.117 |
| Patent ductus arteriosus | 36(43%) | 21(32%) | 15(83%) | 0.001 |
| Atrial septal defect | 66(80%) | 51(78%) | 15(83%) | 0.650 |
| Patent foramen ovale | 34(41%) | 29(45%) | 5(28%) | 0.199 |
| Ventricular septal defect | 1(1%) | 1(2%) | 0(0) | 0.597 |
Risk factors for BPD-PH in VLBWIs by binary logistic regression analysis
| Clinical characteristics | OR | 95%CI | |
|---|---|---|---|
| Birth weight, g | 0.995 | 0.991–0.999 | 0.025 |
| Gestational age, weeks | 1.414 | 0.761–2.628 | 0.273 |
| Duration of O2 therapy, days | 0.988 | 0.937–1.042 | 0.663 |
| Duration of mechanical ventilation, days | 1.021 | 0.964–1.081 | 0.472 |
| Patent ductus arteriosus | 13.355 | 2.950–60.469 | 0.001 |